News

A New Phase

The evolution of clinical trials is accelerating, driven by emerging technologies, social imperatives and the next public health crisis. Click here to view original post

No Picture
News

Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health collaborate on pancreatic cancer research

SAN DIEGO & NEW YORK–(BUSINESS WIRE)–Biological Dynamics, a company commercializing its exosome-isolation ExoVerita™ platform, announced a collaboration with the Perlmutter Cancer Center at NYU Langone Health to validate its application for the early detection of […]

No Picture
News

Eclipsebio Launches eRibo™ for Improved Methods to Profile Protein Translation; Technology Details Will Be Presented at Keystone Symposia

SAN DIEGO–(BUSINESS WIRE)– #RNA–Eclipsebio Launches eRibo™ for Improved Methods to Profile Protein Translation; Technology Details Will Be Presented at Keystone Symposia Click here to view original post

No Picture
News

Biosero and Virscidian Announce Collaboration for Medicinal Chemistry Applications in Drug Discovery

SAN DIEGO & CARY, N.C.–(BUSINESS WIRE)–Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Virscidian, developer of solutions to automate LC/MS (liquid chromatography and mass spectrometry) decision-driven workflows, today announced a collaboration […]

No Picture
News

Rakuten Medical Presented at the 41st Annual J.P. Morgan Healthcare Conference on the Progress of its Pipeline including its Newly Added Antibody-Dye Conjugate RM-0256, Commercial Growth in Japan, and Important Milestones for the Next Few Years

– Leveraging the success in Japan to expand the Alluminox™ platform globally and obtain new approvals as early as 2025 SAN DIEGO, Jan. 30, 2023 /PRNewswire/ — Mickey Mikitani, Co-CEO of Rakuten Medical, Inc. gave […]

No Picture
News

NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2022 Results

SAN DIEGO, Jan. 30, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its […]

No Picture
News

Escient Pharmaceuticals Announces IND Clearance by FDA to Start Phase 1 Study of EP262, a First-in-Class Oral MRGPRX2 Antagonist for Mast Cell Mediated Disorders

SAN DIEGO–(BUSINESS WIRE)–Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced that the U.S. Food and Drug Administration (FDA) has cleared […]

News

FDA advisory committee votes unanimously in favor of bivalent Covid shots replacing primary series

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously in favor of “harmonizing” Covid vaccine compositions, meaning all current vaccine recipients would receive a bivalent vaccine, regardless of whether they’ve gotten their […]

No Picture
News

Amplifica Expands Pipeline for Hair Loss

Exclusive Licensing Agreement Allows for Access to Promising Early-Stage Protein SAN DIEGO, Jan. 26, 2023 /PRNewswire/ — Amplifica Holdings Group, Inc. (“Amplifica”), a privately held, clinical-stage biopharmaceutical company announced the signing of an exclusive license […]

No Picture
News

Ionis Chief Scientific Officer C. Frank Bennett, Ph.D. to receive Rainwater Prize for Outstanding Innovation in Neurodegenerative Disease Research

CARLSBAD, Calif., Jan. 26, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Chief Scientific Officer C. Frank Bennett, Ph.D., has been named a co-recipient of the Rainwater Prize for Outstanding Innovation in […]